Magnetic Resonance Imaging Before Prostate Biopsy: Time to Talk

Anwar R Padhani; Giuseppe Petralia; Francesco Sanguedolce

doi:10.1016/j.eururo.2015.07.036

Magnetic Resonance Imaging Before Prostate Biopsy: Time to Talk

Eur Urol. 2016 Jan;69(1):1-3. doi: 10.1016/j.eururo.2015.07.036. Epub 2015 Aug 8.

Authors

Anwar R Padhani¹, Giuseppe Petralia², Francesco Sanguedolce³

Affiliations

¹ Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Middlesex, UK. Electronic address: anwar.padhani@stricklandscanner.org.uk.
² Division of Radiology, IEO - European Institute of Oncology, Milan, Italy.
³ Northampton General Hospital, NHS Trust, Northampton, UK; King's College Hospital, NHS Foundation Trust, London, UK.

PMID: 26264158
DOI: 10.1016/j.eururo.2015.07.036

Abstract

MRI directed prostate biopsy will change the cancer risk profiles of diagnosed patients, towards those requiring radical treatments. Increased costs can be balanced by improvements in the efficiency of the patient pathway. Effective communication of imaging findings and improved urological understanding of imaging limitations will improve the quality of care for prostate cancer patients.

Publication types

Editorial

MeSH terms

False Negative Reactions
False Positive Reactions
Humans
Image-Guided Biopsy / methods*
Interdisciplinary Communication
Magnetic Resonance Imaging, Interventional*
Male
Patient Selection
Prostate / pathology*